Losavio FA, Lucchini M, De Fino C, Mirabella M, Nociti V.
Transient hair loss during treatment with dimethyl-fumarate for multiple sclerosis. Mult Scler Relat Disord. 2016 ;7:68-9.
INTRODUCTION:Dimethyl-fumarate is a recently approved drug for relapsing-remitting Multiple Sclerosis in Italy.
CLINICAL CASE:A 55-year-old woman started therapy with dimethyl-fumarate on June 2014; it was well-tolerated aside from moderate flushing. Starting September 2014 she noticed a progressive hair loss, that neither the dermatological examination nor clinical and medical history nor blood investigations could explain. The hair loss slowed down after two months and was followed by a hair growth back.
DISCUSSION:Transient hair loss is not a reported side effect of dimethyl-fumarate therapy but by excluding any known cause we attributed it to the beginning of the new therapy.
Aubagio/teriflunomide is known to cause hair thinning, here is a case report of hair loss after Dimethyl fumarate
Labels: dimethyl fumarate